Laddar...
Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL
Insulin lispro 200 U/mL (IL200) is a new strength formulation of insulin lispro (Humalog®, IL100), developed as an option for diabetic patients on higher daily mealtime insulin doses. This phase 1, open‐label, 2‐sequence, 4‐period crossover, randomized, 8‐hour euglycemic clamp study aimed to demonst...
Sparad:
| I publikationen: | Clin Pharmacol Drug Dev |
|---|---|
| Huvudupphovsmän: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5054907/ https://ncbi.nlm.nih.gov/pubmed/27119580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.221 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|